K
Kelly B. Collins
Researcher at United States Military Academy
Publications - 5
Citations - 1510
Kelly B. Collins is an academic researcher from United States Military Academy. The author has contributed to research in topics: HIV vaccine & Cellular immunity. The author has an hindex of 5, co-authored 5 publications receiving 1494 citations.
Papers
More filters
Journal ArticleDOI
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
John W. Shiver,Tong-Ming Fu,Ling Chen,Danilo R. Casimiro,Mary-Ellen Davies,Robert K. Evans,Zhiqiang Zhang,Adam J. Simon,Wendy L. Trigona,Sheri Dubey,Lingyi Huang,Virginia Harris,Romnie Long,Xiaoping Liang,Larry Handt,William A. Schleif,Lan Zhu,Daniel C. Freed,Natasha Persaud,Liming Guan,Kara Punt,Aimin Tang,Minchun Chen,Keith A. Wilson,Kelly B. Collins,Gwendolyn J. Heidecker,V. Rose Fernandez,Helen C. Perry,Joseph G. Joyce,Karen M. Grimm,James C. Cook,Paul M. Keller,Denise S. Kresock,Henryk Mach,Robert D. Troutman,Lynne Isopi,Donna M. Williams,Zheng Xu,Kathryn E. Bohannon,David B. Volkin,David C. Montefiori,Ayako Miura,Georgia R. Krivulka,Michelle A. Lifton,Marcelo J. Kuroda,Jörn E. Schmitz,Norman L. Letvin,Michael J. Caulfield,Andrew J. Bett,Rima Youil,David C. Kaslow,Emilio A. Emini +51 more
TL;DR: The replication-defective adenovirus is a promising vaccine vector for development of an HIV-1 vaccine and elicited by a replication-incompetent Ad5 vector, used either alone or as a booster inoculation after priming with a DNA vector.
Journal ArticleDOI
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay.
Sheri Dubey,James H. Clair,Tong-Ming Fu,Liming Guan,Romnie Long,Robin Mogg,Kiersten Anderson,Kelly B. Collins,Christine Gaunt,V. Rose Fernandez,Lan Zhu,Lisa Kierstead,Scott Thaler,Swati B. Gupta,Walter L. Straus,Devan V. Mehrotra,Timothy W. Tobery,Danilo R. Casimiro,John W. Shiver +18 more
TL;DR: These studies show that the validated ELISPOT assay using 15mer peptide pools and the positivity criteria of ≥55 spots per 106 cells and ≥4-fold over mock (negative control) is a sensitive and specific assay for the detection of HIV vaccine-induced cell-mediated immunity.
Journal ArticleDOI
Cross-Reactivity of Anti–HIV-1 T Cell Immune Responses among the Major HIV-1 Clades in HIV-1–Positive Individuals from 4 Continents
Paul Coplan,Swati B. Gupta,Sheri Dubey,Punnee Pitisuttithum,Alex Nikas,Bernard Mbewe,Efthyia Vardas,Mauro Schechter,Esper G. Kallas,Dan C. Freed,Tong-Ming Fu,Christopher T. Mast,Pilaipan Puthavathana,James Kublin,Kelly B. Collins,John Chisi,Richard Pendame,Scott Thaler,Glenda Gray,James McIntyre,Walter L. Straus,Jon H. Condra,Devan V. Mehrotra,Harry A. Guess,Emilio A. Emini,John W. Shiver +25 more
TL;DR: Cross-clade reactivity of cellular immune responses can be substantial but varies by viral protein, and predominantly focused on viral Gag and Nef proteins.
Journal ArticleDOI
Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC.
Lisa Kierstead,Sheri Dubey,Barbara Meyer,Timothy W. Tobery,Robin Mogg,V. Rose Fernandez,Romnie Long,Liming Guan,Christine Gaunt,Kelly B. Collins,Kara J. Sykes,Devan V. Mehrotra,Narendra Chirmule,John W. Shiver,Danilo R. Casimiro +14 more
TL;DR: The importance of optimal conditions for PBMC collection and handling to the success of a clinical development program is established and the estimated immunologic response rates to an adenovirus- based HIV vaccine increased by more than 20 percentage points.
Journal ArticleDOI
Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans.
Andrew J. Bett,Sheri Dubey,Devan V. Mehrotra,Liming Guan,Romnie Long,Kiersten Anderson,Kelly B. Collins,Christine Gaunt,Rose Fernandez,Suzanne Cole,Steve Meschino,Aimin Tang,Xiao Sun,Sanjay Gurunathan,Jim Tartaglia,Michael N. Robertson,John W. Shiver,Danilo R. Casimiro +17 more
TL;DR: Although the immunogenicity of the vaccines and vaccine regimens evaluated were not all accurately predicted, testing in rhesus macaques generally offers an indispensable tool for ranking the immunological potential of HIV-1 vaccine candidates.